1. Bauernfeind, A., Bertele, R. M., Harms, K., Hörl, G., Jungwirth, R., Petermüller, C., Przyklenk, B., Weisslein-Pfister, C. Qualitative and quantitative microbiological analysis of 102 patients with cystic fibrosis. Infection 15 (1987) 270–277.
2. Bauernfeind, A., Harms, K., Bertele, R. M., Petermüller, C., Przyklenk, G. Importance of bacteriological data for antibiotic therapy in patients with cystic fibrosis. In:Simon, C., Wilkinson, P. (eds.): Diagnosis of infectious diseases — new aspects. Schattauer Stuttgart, New York, 1986 pp. 149–155.
3. DIN 58 940. Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika. Normenausschuß Medizin (1986). Beiblatt 2, Teil 4.
4. Sörgel, F., Stephan, U., Stehr, C., Koch, U., Rey, M., Wiesemann, H. G., Dominick, H. C., Böwing, H. B., Geldmacher von Malliinckrodt, M. High dose treatment with antibiotics in cystic fibrosis — A reappraisal with special reference to betalactames and new fluoroquinolones. Infection 15 (1987) 385–396.
5. Bergogne-Berezin, E. Rational parameters of antiinfective therapy in cystic fibrosis patients. Infection 15 (1987) 288–294.